Cargando…
Tirzepatide: A Systematic Update
Tirzepatide is a new molecule capable of controlling glucose blood levels by combining the dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. GIP and GLP1 are incretin hormones: they are released in the intestine in response to nutrient...
Autores principales: | Forzano, Imma, Varzideh, Fahimeh, Avvisato, Roberta, Jankauskas, Stanislovas S., Mone, Pasquale, Santulli, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741068/ https://www.ncbi.nlm.nih.gov/pubmed/36498958 http://dx.doi.org/10.3390/ijms232314631 |
Ejemplares similares
-
L-Arginine in diabetes: clinical and preclinical evidence
por: Forzano, Imma, et al.
Publicado: (2023) -
Correction: L-Arginine in diabetes: clinical and preclinical evidence
por: Forzano, Imma, et al.
Publicado: (2023) -
The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
por: Forzano, Imma, et al.
Publicado: (2022) -
Functional Role of Taurine in Aging and Cardiovascular Health: An Updated Overview
por: Santulli, Gaetano, et al.
Publicado: (2023) -
miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
por: Kansakar, Urna, et al.
Publicado: (2022)